Direct cell reprogramming for tissue engineering and regenerative medicine

Journal of Biological Engineering
Alexander Grath, Guohao Dai

Abstract

Direct cell reprogramming, also called transdifferentiation, allows for the reprogramming of one somatic cell type directly into another, without the need to transition through an induced pluripotent state. Thus, it is an attractive approach to develop novel tissue engineering applications to treat diseases and injuries where there is a shortage of proliferating cells for tissue repair. In certain tissue damage, terminally differentiated somatic cells lose their ability to proliferate, as a result, damaged tissues cannot heal by themselves. Examples of these scenarios include myocardial infarctions, neurodegenerative diseases, and cartilage injuries. Transdifferentiation is capable of reprogramming cells that are abundant in the body into desired cell phenotypes that are able to restore tissue function in damaged areas. Therefore, direct cell reprogramming is a promising direction in the cell and tissue engineering and regenerative medicine fields. In recent years, several methods for transdifferentiation have been developed, ranging from the overexpression of transcription factors via viral vectors, to small molecules, to clustered regularly interspaced short palindromic repeats (CRISPR) and its associated protein (Cas9) for b...Continue Reading

References

May 4, 2001·Diabetes·J C LeeM S German
Jun 8, 2001·Annual Review of Biochemistry·S Y RothC D Allis
Dec 20, 2002·Mechanisms of Development·Chia Ning ShenDavid Tosh
May 29, 2004·Tissue Engineering·Jeannette JustesenMoustapha Kassem
Aug 23, 2006·Cell·Adam J EnglerDennis E Discher
Apr 22, 2008·International Journal of Cancer. Journal International Du Cancer·Carlo Stresemann, Frank Lyko
Aug 30, 2008·Nature·Qiao ZhouDouglas A Melton
Jan 29, 2010·Nature·Thomas VierbuchenMarius Wernig
Mar 26, 2010·Stem Cell Reviews and Reports·Minal Patel, Shuying Yang
Aug 9, 2011·Proceedings of the National Academy of Sciences of the United States of America·Hiroshi BanShin-Ichi Nishikawa
Nov 23, 2011·Cell Research·Fengxi MengJianwei Jiao
Jan 10, 2012·Methods in Molecular Biology·Richard P MetzEmily Wilson
Aug 8, 2012·Proceedings of the National Academy of Sciences of the United States of America·Andriana MargaritiQingbo Xu
Sep 6, 2012·Proceedings of the National Academy of Sciences of the United States of America·Anannya BangaJonathan M W Slack
Jan 5, 2013·Science·Le CongFeng Zhang
Jan 22, 2013·Nature Cell Biology·Caroline Rouaux, Paola Arlotta
Mar 27, 2013·Proceedings of the National Academy of Sciences of the United States of America·Olof TorperMalin Parmar
Oct 9, 2013·Journal of Cell Science·Chibeza C AgleyStephen D R Harridge
Nov 20, 2013·Progress in Neurobiology·Margherita RuggieriStefania Corti
Jun 7, 2014·Frontiers in Pharmacology·Ryan T Kendall, Carol A Feghali-Bostwick
Aug 5, 2014·Cellular Reprogramming·Keerat KaurLeonard M Eisenberg
Dec 3, 2014·Stem Cell Reports·Syandan ChakrabortyKam W Leong
Dec 6, 2014·Cell Death and Differentiation·M LemperL Baeyens
Dec 30, 2014·Proceedings of the National Academy of Sciences of the United States of America·Rimpei MoritaAkihiko Yoshimura
Mar 3, 2015·Nature Methods·Alejandro ChavezGeorge M Church

❮ Previous
Next ❯

Citations

May 1, 2020·Frontiers in Cardiovascular Medicine·Andras P DurkoJolanda Kluin
Jan 11, 2020·Frontiers in Molecular Neuroscience·Mitsuto SatoYoshitsugu Aoki
Mar 13, 2020·Translational Neuroscience·Kuangpin LiuLiyan Li
Oct 6, 2020·Frontiers in Cell and Developmental Biology·Valentin Milichko, Vyacheslav Dyachuk
Oct 22, 2020·International Journal of Molecular Sciences·Lin JiangYigang Wang
Aug 28, 2020·Bioinformatics·Cui Su, Jun Pang
Dec 9, 2020·Wiley Interdisciplinary Reviews. Systems Biology and Medicine·Gabrielle A DotsonIndika Rajapakse
Jan 5, 2021·Advanced Functional Materials·Dantong HuangKam W Leong
Mar 6, 2021·Neurochemical Research·Cristiana Mollinari, Daniela Merlo
Mar 14, 2021·Nature Communications·Sascha JungAntonio Del Sol
Mar 14, 2021·Bulletin of Experimental Biology and Medicine·N K Yarygina, K N Yarygin
Jun 8, 2021·Neuroscience Bulletin·Jiali ShiZhihui Huang
Jul 25, 2021·Clinical Epigenetics·Amitava Basu, Vijay K Tiwari

❮ Previous
Next ❯

Methods Mentioned

BETA
transdifferentiation
transfection
acetylating
xenografts
transgenic

Software Mentioned

SunTag

Related Concepts

Related Feeds

Cell-Type Specific Viral Vectors

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

Cell-Type-Specific Viral Vectors (ASM)

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

CRISPR (general)

Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). CRISPR-Cas system enables the editing of genes to create or correct mutations. Discover the latest research on CRISPR here.

CRISPR for Genome Editing

Genome editing technologies enable the editing of genes to create or correct mutations. Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). Here is the latest research on the use of CRISPR-Cas system in gene editing.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Cell-Type-Specific Viral Vectors

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.